Evaluating Tumor Heterogeneity with a High Throughput Pipeline
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
In this symposium, an expert panel will discuss how cutting-edge organoid research lends insights into normal development and shows what happens when processes go awry.
Mammary organoids derived from mouse embryonic stem cells could offer clues into mammary gland developmental origins and help researchers study breast cancer.
In this webinar, Elizabeth Proctor will discuss the latest organoid models that scientists use to advance human disease research, with a focus on promoting drug discovery and precision medicine.